Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
about
Truncated product of the bifunctional DLST gene involved in biogenesis of the respiratory chainOverview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal CompoundsMitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based TherapiesMitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionPathogenesis of Alzheimer's diseaseMutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer diseaseMitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease.The neurodegenerative mitochondriopathies.Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change?Amyloid-Beta interaction with mitochondriaMitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects.Aβ oligomers-induced toxicity is attenuated in cells cultured with NbActiv4™ mediumBrain aging, Alzheimer's disease, and mitochondria.Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairmentReduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.New insights in the amyloid-Beta interaction with mitochondriaMitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.Antioxidant therapies for Alzheimer's diseaseLow-level laser therapy for beta amyloid toxicity in rat hippocampus.PET sheds light on Alzheimer's disease genetic riskProspects for redox-based therapy in neurodegenerative diseases.Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases.Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenesThe amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristaeAmyloid-beta-induced mitochondrial dysfunction.Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.The Alzheimer's disease mitochondrial cascade hypothesis: an updateBioenergetic medicine.Role of platelets in neurodegenerative diseases: a universal pathophysiology.Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.Mitochondria, Cybrids, Aging, and Alzheimer's Disease.Amyloid precursor protein processing and bioenergetics.Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.Brain energy metabolizing enzymes in Alzheimer's disease: alpha-ketoglutarate dehydrogenase complex and cytochrome oxidase.Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities.
P2860
Q24679782-F551B7A0-561A-4AFA-967C-2EB4995FE0A7Q26749061-95F6DED0-0CBA-4464-A18E-A5243807D0C4Q26750081-00FF697D-030E-481B-8DC2-D9FBF1FEE409Q26865358-475C6CD6-B0C3-4F8B-8255-D894E78E2DE6Q30439489-38BA91D1-09BB-425A-B08E-D1B6C6535E52Q30454431-BC9D824A-164E-47D5-BFA7-6FD6B82B6468Q33585950-B24D310C-ED62-4025-AF41-4CF000407BB0Q33603263-2E3FC0D3-E395-4DCC-A2F1-F0B9BB34588EQ33783000-891E4B2C-11E6-4319-A4FD-E707C38CDDC6Q33836235-26C966F5-CE35-42FE-82A3-11192987B81DQ33957065-637BD49B-10B7-4C5D-9536-C99AA724CB96Q34490690-50F65062-30B1-4EBE-A3E1-2116CD518B0FQ34725635-777CCAD4-5DA9-41A6-88A0-B82D74E55493Q34981294-8B3BBE32-15B9-4ED7-B94F-3F54EC480C8CQ35327150-CBCB5398-0496-442E-AD98-1EA3F93AAEABQ35533354-5ED6DDF3-4AC4-4A4A-A998-C3681021D2B3Q35781535-88666FF1-F39D-4050-9427-3A3020D405A4Q35795672-FA8631EF-976B-48BB-9BE2-A8DCB227E812Q35864854-791C5A4F-3FB3-4CC5-B592-3728B6E787F0Q35898628-71F0B7EF-DBAD-480C-A278-BB42DAD38E6EQ35916588-410F14F2-2449-444C-86AD-B71A73213941Q36135040-252BA9A2-4C0A-4943-85A4-F6163A4F092EQ36183441-3666EA61-7618-443C-9763-30E9573D891FQ36277092-4931D960-FDEA-4F12-89DC-1270E738A06FQ36513552-B72A4C7E-9AC1-47D8-92EA-9B9541DC380AQ36573774-98061C7F-71E3-41D2-ADF5-6422E48A0038Q36833539-8BE6F0E2-34F1-4CC9-A58E-D953D5C49012Q36856671-C83D218E-B333-4702-9060-0A5DD3629FBBQ36942358-B31FCE37-84E6-4A22-84C9-036D00B2942DQ36998837-F04A7F40-1293-4014-9EF2-A8E1DD75EEDCQ37261159-15850EBB-70F4-416C-9423-D4D7829285C4Q37686246-19556FDE-8285-4E40-8CAB-094C94F78A3CQ38072757-97B08332-F884-4223-AF40-7E4050AF3A04Q38890523-2AF3E63F-9A02-4C69-B546-19E77B01485CQ38932850-F3063049-885C-463B-A4CF-660B2725EC75Q38933148-BCB48449-8A18-4619-815A-E2469E40CC9CQ38962796-DAF907E2-DD96-4967-85C9-A2FD90BBD35BQ39026385-B8D8EC2D-1BBF-4A1C-BD4E-1896CA0766A7Q41611084-B52E9F5E-00FC-4C7D-95F6-5416EA5014B0Q43858152-BAA451F9-750F-41DE-9DBC-268D3B0697CA
P2860
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
@ast
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
@en
type
label
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
@ast
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
@en
prefLabel
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
@ast
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
@en
P356
P1433
P1476
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.
@en
P2093
Parker WD Jr
P304
P356
10.1212/WNL.45.3.482
P407
P433
P577
1995-03-01T00:00:00Z